Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities
Playback speed
10 seconds
Case Presentations/Panel Discussion: 80 y/o M With Melanoma, 67 y/o M With Stage 3A NSCLC, 55 y/o F With Metastatic Melanoma
46 views
March 17, 2022
Comments 0
Login to view comments.
Click here to Login
Videos